Business Standard

Thursday, December 26, 2024 | 01:32 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

GlaxoSmithKline Pharmaceuticals zooms 17% on 1:1 bonus

The stock surged 17% to Rs 3,249, also its 52-week high on the BSE, after its board recommended a bonus issue in the ratio of 1:1.

GlaxoSmithKline, GSK
Premium

.

SI Reporter Mumbai
Shares of GlaxoSmithKline Pharmaceuticals have zoomed 17% to Rs 3,249 per share, also their 52-week high on the BSE, after the company's board recommended a bonus issue in the ratio of 1:1.

“The Board considered, approved and recommended a bonus issue of one equity share for every equity share held as on a record date to be determined,” GlaxoSmithKline Pharmaceuticals said in a press release.

The pharmaceutical company has reported more the doubled net profit at Rs 886 million for June 2018 quarter (Q1FY19), on back of strong operational performance. It had profit of Rs 264 million in

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in